Application

18425954 · Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

Filed 2024-01-29 · Granted · Patent 12514906 (2026-01-06) The official file ↗The patent and its PDF ↗ · Art unit 1674 · Examiner Xiaozhen Xie Typical · CPC A61K 9/19 · BIOMARIN PHARMACEUTICAL INC. · Marshall, Gerstein & Borun LLP (Biomarin)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

11.7 mo

to disposition 23.3 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.